InsidersTradesSigma
Explore the complete record of transactions filed by RALLIS CHRIS A, Director. Officer active across 1 companies, notably Fennec Pharmaceuticals INC.. In total, 3 reports have been published. The latest transaction was disclosed on 8 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Chris A. Rallis is a Board Member of Fennec Pharmaceuticals Inc., where he contributes to the governance and strategy of the company. His experience in the pharmaceutical sector is valuable to the board, allowing him to make informed decisions.